Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04434352 · ClinicalTrials.gov registry record · NA

Low Intensity Shockwave Therapy for Erectile Dysfunction

A NA study of Erectile Dysfunction and Erectile Dysfunction Following Radical Prostatectomy, sponsored by University of Virginia.

Active
Registry status
NA
Development phase
338
Enrollment target
1
Study location

NCT04434352 is a NA study of Erectile Dysfunction and Erectile Dysfunction Following Radical Prostatectomy that is active but no longer recruiting, run by University of Virginia. The registered enrollment target is 338 participants, above the 221-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (53% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04434352, a NA study of Erectile Dysfunction and Erectile Dysfunction Following Radical Prostatectomy, is active but no longer recruiting, sponsored by University of Virginia.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
338 participants
Enrollment target
1
Study location

Study Summary

Low-intensity shockwave therapy (LiSWT) has been deemed "a safe and well-tolerated procedure but its efficacy for the treatment of ED is doubtful and deserves more investigation" by the European Society of Sexual Medicine. In a similar manner, the Sexual Medicine Society of North America and American Urological Association have put forth guideline statements recommending additional investigation of this treatment modality.2 The current clinical armamentarium only treats the symptoms of erectile dysfunction without improving upon the underlying pathophysiology. LiSWT has been used effectively in musculoskeletal disorders and cardiovascular applications. Animal studies have shown improvements in angiogenesis and stem cell recruitment in other systems (cardiac and musculoskeletal) using shockwave therapy. It has been used to treat erectile dysfunction since 2010 and is widely used in Europe and throughout the world. It is gaining widespread acceptance in the United States with a relative paucity of data in regards to its effectiveness. While the majority of studies and meta-analyses show improvements in standardized erectile dysfunction questionnaires (IIEF/SHIM-Sexual Health Inventory in Men, International Index of Erectile Function-5) the durability remains unknown and many have lacked a sham-arm. In addition, many studies have failed to assess a population of men who have highly prevalent erectile dysfunction, those men undergoing prostate cancer treatment. This is a prospective, randomized, single blind, sham-controlled clinical study aimed to evaluate the safety and efficacy of low-intensity shockwave therapy (LiSWT) on symptomatic ED patients in three distinct patient populations. LiSWT has shown the potential to improve baseline erectile function but requires further study, which is the aim of this investigation.

Interventions

  • DEVICE Storz Duolith Low-Intensity Shockwave Therapy

Study Locations (1)

Virginia

  • University of Virginia - Charlottesville

Trial Details

FieldValue
Enrollment Target 338 participants
Start Date 2020-06-01
Est. Completion 2025-01-09
Phase NA

Sponsor

University of Virginia

449 total trials

What the Registry Record Tells You About NCT04434352

The ClinicalTrials.gov registry entry for NCT04434352 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 338 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 221-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (53% higher). The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Erectile Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which Storz Duolith Low-Intensity Shockwave Therapy is the first listed.

NCT04434352 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT04434352 about?

NCT04434352 is a clinical study titled "Low Intensity Shockwave Therapy for Erectile Dysfunction". Low-intensity shockwave therapy (LiSWT) has been deemed "a safe and well-tolerated procedure but its efficacy for the treatment of ED is doubtful and deserves more investigation" by the European Society of Sexual Medicine. In a similar manner, the Sexual Medicine Society of North America and America...

What is the current status of trial NCT04434352?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 338 participants. The study started on 2020-06-01. Estimated completion is 2025-01-09.

What conditions does trial NCT04434352 study?

This clinical trial studies the following conditions: Erectile Dysfunction, Erectile Dysfunction Following Radical Prostatectomy, Erectile Dysfunction Due to Arterial Insufficiency, Erectile Dysfunction Following Radiation Therapy, Erectile Dysfunction Due to General Medical Condition.

What interventions are being tested in trial NCT04434352?

The interventions under investigation include: Storz Duolith Low-Intensity Shockwave Therapy (DEVICE).

Who is sponsoring clinical trial NCT04434352?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04434352 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Erectile Dysfunction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.